Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025)

Benitec Biopharma has reported Non-Current Assets for 7 years, with the latest figure at $1.1 million in Q4 2025.

• Quarterly Non-Current Assets rose 205.92% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$100.9 million (down 5240.19% YoY) and the FY2025 annual result came in at $1.1 million, up 100.37% from the prior year.
• Non-Current Assets grew to $1.1 million in Q4 2025 per BNTC's latest filing, from $948000.0 in the prior quarter.
• Over five years, Non-Current Assets peaked at $1.5 million in Q3 2021 and troughed at -$104.0 million in Q1 2025.
• A 5-year average of -$4.4 million and a median of $877500.0 in 2022 frame the typical range for Non-Current Assets.
• The widest YoY moves for Non-Current Assets: up 205.92% in 2025, down 16531.28% in 2025.
• Over 5 years, Non-Current Assets stood at $1.3 million in 2021, then plunged by 30.7% to $930000.0 in 2022, then plunged by 40.11% to $557000.0 in 2023, then slumped by 36.27% to $355000.0 in 2024, then surged by 205.92% to $1.1 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $1.1 million, $948000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.